Agilent's second quarter results were strong, with revenue and EPS growth exceeding expectations. The company saw robust performance across regions and segments, particularly in PFAS testing and digital orders. However, challenges such as incremental tariff costs and slower biopharma recovery were noted.

Company Guidance -

Q3 2025

During the second quarter of fiscal year 2025, Agilent Technologies Inc. delivered robust financial results, with reported revenue reaching $1.67 billion, reflecting a growth of 6% over the same period in 2024, and core revenue increasing by 5.3%. The company achieved an operating margin of 25.1% despite facing incremental tariff costs and reported earnings per share (EPS) of $1.31, marking a 7% increase year-over-year. Agilent's performance was bolstered by diverse market growth, particularly in China, which saw a 10% revenue increase, and India, which experienced high teens growth. Diagnostics and Clinical sectors posted an 8% growth, while Environmental and Forensics grew by 6%, driven by strong demand for PFAS testing, which surged over 70% globally. Agilent is maintaining its full-year core growth guidance of 2.5% to 3.5% while integrating favorable currency movements, projecting full-year reported revenue between $6.73 billion and $6.81 billion, and affirming its EPS guidance of $5.54 to $5.61 for the fiscal year.

Revenue and EPS Growth Exceed Expectations

Agilent reported revenue of $1.67 billion for the second quarter, marking a growth of 6% reported and 5.3% core compared to the previous year. EPS grew by 7%, exceeding expectations and marking the fourth consecutive quarter of accelerating growth.

Strong Regional Performance

China led regional growth with a 10% increase, while the rest of Asia grew in high single digits. India delivered high teens growth, showcasing its potential as a long-term high-growth market.

PFAS Testing Demand Surge

PFAS testing demand grew over 70% year-over-year globally, with Europe and China more than doubling their business. This provided an incremental 80 basis points to growth in the quarter.

Successful Product Launches

Agilent launched impactful new products including the Seahorse XF Flex analyzer and the InfinityLab Pro iQ series, highlighting continued commitment to innovation.

Digital Orders Growth

Digital orders grew by 12% year-over-year to $295 million, reflecting successful investments in the digital ecosystem.

Agilent (A) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

A Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 27, 2025	2025 (Q3)	1.37 / -	1.32	―	―	―
May 28, 2025	2025 (Q2)	1.26 / 1.31	1.22	7.38% (+0.09)
Feb 26, 2025	2025 (Q1)	1.28 / 1.31	1.29	1.55% (+0.02)
Nov 25, 2024	2024 (Q4)	1.41 / 1.46	1.38	5.80% (+0.08)
Aug 21, 2024	2024 (Q3)	1.26 / 1.32	1.43	-7.69% (-0.11)
May 29, 2024	2024 (Q2)	1.19 / 1.22	1.27	-3.94% (-0.05)
Feb 27, 2024	2024 (Q1)	1.23 / 1.29	1.37	-5.84% (-0.08)
Nov 20, 2023	2023 (Q4)	1.34 / 1.38	1.53	-9.80% (-0.15)
Aug 15, 2023	2023 (Q3)	1.36 / 1.43	1.34	6.72% (+0.09)
May 23, 2023	2023 (Q2)	1.26 / 1.27	1.13	12.39% (+0.14)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

A Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 28, 2025	$110.65	$113.04	+2.16%
Feb 26, 2025	$133.90	$126.54	-5.50%
Nov 25, 2024	$133.68	$133.56	-0.09%
Aug 21, 2024	$138.92	$139.15	+0.17%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.